ADAM15 Disintegrin Is Associated with Aggressive Prostate and Breast Cancer Disease
Open Access
- 1 April 2006
- journal article
- Published by Elsevier BV in Neoplasia
- Vol. 8 (4), 319-329
- https://doi.org/10.1593/neo.05682
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- ADAM15 decreases integrin αvβ3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashionThe International Journal of Biochemistry & Cell Biology, 2005
- Membrane associated proteases and their inhibitors in tumour angiogenesisJournal of Clinical Pathology, 2004
- Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomasInternational Journal of Cancer, 2004
- Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasionOncogene, 2003
- The Role of ADAM 15 in Glomerular Mesangial Cell MigrationPublished by Elsevier BV ,2002
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- ADAM 12-S Cleaves IGFBP-3 and IGFBP-5 and Is Inhibited by TIMP-3Biochemical and Biophysical Research Communications, 2000
- An Essential Role for Ectodomain Shedding in Mammalian DevelopmentScience, 1998
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Expression of Members of the Novel Membrane Linked Metalloproteinase Family ADAM in Cells Derived from a Range of Haematological MalignanciesBiochemical and Biophysical Research Communications, 1997